You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mFOLFIRINOX

Showing 26 - 50 of 98
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Pancreas Trial in Morgantown (Hydroxychloroquine sulfate)

Recruiting
  • Adenocarcinoma of the Pancreas
  • Hydroxychloroquine sulfate
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Aug 2, 2021

Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

Recruiting
  • Liver and Intrahepatic Bile Duct Carcinoma
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 11, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Leucovorin Calcium
  • +4 more
  • 's-Hertogenbosch, Netherlands
  • +19 more
Jan 6, 2023

Pancreatic Cancer Trial in Australia (radiation, drug, procedure)

Recruiting
  • Pancreatic Cancer
  • Stereotactic Radiotherapy (SBRT)
  • +4 more
  • Camperdown, New South Wales, Australia
  • +10 more
Oct 15, 2021

Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Houston, Texas
  • +1 more
Dec 15, 2022

Pancreatic Ductal Adenocarcinoma Trial (JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Feb 16, 2022

Pancreatic Carcinoma Trial in France (drug, radiation, procedure)

Recruiting
  • Pancreatic Carcinoma
  • mFolfirinox
  • +3 more
  • Bordeaux, France
  • +27 more
Mar 29, 2022

Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)

Recruiting
  • Stage III Colon Cancer
  • Signatera test
  • +5 more
  • Pittsburgh, Pennsylvania
    NRG Oncology - Pittsburgh Center
Mar 30, 2022

Resected Pancreatic Adenocarcinoma Trial in Washington (mFOLFIRINOX, Proton beam radiation)

Recruiting
  • Resected Pancreatic Adenocarcinoma
  • mFOLFIRINOX
  • Proton beam radiation
  • Washington, District of Columbia
    Georgetown University Medical Center - Lombardi Comprehensive Ca
Jul 27, 2021

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))

Recruiting
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +3 more
Aug 17, 2022

Colorectal Tumors Trial in São Paulo (Folfirinox)

Recruiting
  • Colorectal Neoplasms
  • São Paulo, Brazil
    Hospital Municipal Vila Santa Catarina
Oct 5, 2021

Pancreatic Cancer Trial in Shanghai (Fluzoparib)

Recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Dec 30, 2020

Pancreatic Adenocarcinoma (Ductal Adenocarcinoma) Trial in Canada, France (mFolfirinox, Gemcitabine)

Completed
  • Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
  • Calgary, Alberta, Canada
  • +51 more
Jan 3, 2022

Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic

Unknown status
  • Cholangiocarcinoma of the Bile Duct
    • Shanghai, Shanghai, China
      Xinhua Hospital
    Dec 30, 2020

    Advanced Pancreatic Cancer Trial in Shanghai, Hangzhou (Fluzoparib, Fluzoparib , mFOLFIRINOX)

    Recruiting
    • Advanced Pancreatic Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Aug 9, 2020

    Pancreas Ductal Adenocarcinoma Trial in Italy (PAXG, mFOLFIRINOX, short-course chemo)

    Recruiting
    • Pancreas Ductal Adenocarcinoma
    • Aviano, Italy
    • +21 more
    Mar 10, 2021

    Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

    Recruiting
    • Borderline Resectable Pancreatic Carcinoma
    • +8 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Aug 25, 2022

    Pancreatic Adenocarcinoma Trial (Nab paclitaxel, Gemcitabine, mFOLFIRINOX)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Nab paclitaxel
    • +2 more
    • (no location specified)
    Apr 6, 2021

    Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

    Active, not recruiting
    • Pancreatic Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Jan 12, 2022

    Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

    Recruiting
    • Pancreatic Cancer
    • Sydney, New South Wales, Australia
    • +2 more
    Oct 19, 2023

    Cancer of the Rectum Trial in France (drug, radiation, procedure)

    Active, not recruiting
    • Cancer of the Rectum
    • mFolfirinox
    • +4 more
    • Amiens, France
    • +35 more
    Jul 20, 2021

    Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in United States (Gemcitabine combined with

    Recruiting
    • Metastatic Pancreatic Cancer
    • Metastatic Pancreatic Adenocarcinoma
    • Gemcitabine combined with nab-paclitaxel
    • +4 more
    • La Jolla, California
    • +20 more
    Aug 18, 2022

    Pancreatic Cancer Resectable Trial in Guangzhou (mFOLFORINOX)

    Not yet recruiting
    • Pancreatic Cancer Resectable
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jan 15, 2020

    Bile Duct Cancer Trial in France (GEMCIS, mFolfirinox)

    Completed
    • Bile Duct Cancer
    • Amiens, France
    • +41 more
    Feb 23, 2022